PD-L1: expression regulation

PD-L1: expression regulation

Programmed death-ligand 1 (PD-L1), expressed on the surface of tumor cells, can bind to programmed cell death-1 (PD-1) on T cells. The interaction of PD-1 and PD-L1 can inhibit T-cell responses by decreasing T-cell activity and accelerating their apoptosis. Various cancers express high levels of PD-...

Full description

Bibliographic Details
Main Authors:	Yu-Jie Zhou, Guoli Li, Jiyin Wang, Mengyuan Liu, Zihan Wang, Yu Song, Xulong Zhang, Xi Wang
Format:	Article
Language:	English
Published:	Wolters Kluwer Health 2023-04-01
Series:	Blood Science
Online Access:	http://journals.lww.com/10.1097/BS9.0000000000000149

Similar Items

Role of regulation of PD-1 and PD-L1 expression in sepsis
by: Teng Zhang, et al.
Published: (2023-03-01)

CMTM6, the newly identified PD-L1 regulator, correlates with PD-L1 expression in lung cancers
by: Feng Gao, et al.
Published: (2019-12-01)

Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis
by: Jie Yang, et al.
Published: (2024-08-01)

PD-L1 expression is regulated by ATP-binding of the ERBB3 pseudokinase domain
by: Yamu Li, et al.
Published: (2023-07-01)

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer
by: Chenlu Zhang, et al.
Published: (2018-04-01)

Expression and Clinical Significance of PD-1 and PD-L1 in Pulmonary Carcinoids
by: Mingbiao LI, et al.
Published: (2016-12-01)

Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
by: Angel Garcia-Diaz, et al.
Published: (2017-05-01)

Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
by: Chengliang Sun, et al.
Published: (2022-12-01)

Factors correlating the expression of PD-L1
by: Fang Lu, et al.
Published: (2024-05-01)

PTEN loss increases PD-L1 protein expression and affects the correlation between PD-L1 expression and clinical parameters in colorectal cancer.
by: Minmin Song, et al.
Published: (2013-01-01)

MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC
by: Wei-Bin Xie, et al.
Published: (2018-03-01)

New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities
by: Mengyuan Dai, et al.
Published: (2022-11-01)

ZG16 regulates PD-L1 expression and promotes local immunity in colon cancer
by: Hui Meng, et al.
Published: (2021-02-01)

PD-L1-expressing natural killer cells predict favorable prognosis and response to PD-1/PD-L1 blockade in neuroblastoma
by: Mengjia Song, et al.
Published: (2024-12-01)

Immunological Mechanisms behind Anti-PD-1/PD-L1 Immune Checkpoint Blockade: Intratumoral Reinvigoration or Systemic Induction?
by: Zhikun Guo, et al.
Published: (2024-03-01)

Correction: New insights into epigenetic regulation of resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms and therapeutic opportunities
by: Mengyuan Dai, et al.
Published: (2022-12-01)

Current insight into the regulation of PD-L1 in cancer
by: Zhuandi Liu, et al.
Published: (2022-07-01)

The changes in peripheral blood Th17 and Treg ratios in Hashimoto’s thyroiditis are accompanied by differential PD-1/PD-L1 expression
by: Jun Fang, et al.
Published: (2022-08-01)

Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
by: Xin Wang, et al.
Published: (2019-02-01)

LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
by: Zhengwei Song, et al.
Published: (2022-09-01)

Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma
by: Xingming Zhang, et al.
Published: (2019-04-01)

Relevance of specific oncolytic adenovirus in regulating PD-L1 expression in prostate cancer
by: Di Zhang, et al.
Published: (2023-05-01)

Self-supervised contrastive learning using CT images for PD-1/PD-L1 expression prediction in hepatocellular carcinoma
by: Tianshu Xie, et al.
Published: (2023-03-01)

Consistent expression of PD-L1 in tumor microenvironment with peripheral PD-1/PD-L1 in circulating T lymphocytes of operable breast cancer: a diagnostic test
by: Keyu Yuan, et al.
Published: (2022-09-01)

CD24 May Serve as an Immunotherapy Target in Triple-Negative Breast Cancer by Regulating the Expression of PD-L1
by: Zhu X, et al.
Published: (2023-12-01)

KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
by: Jinghan Li, et al.
Published: (2024-02-01)

B4GALT1 promotes immune escape by regulating the expression of PD-L1 at multiple levels in lung adenocarcinoma
by: Yanan Cui, et al.
Published: (2023-06-01)

Association of PD-1/PD-L1 expression and Epstein-–Barr virus infection in patients with invasive breast cancer
by: Wei-tong Zhang, et al.
Published: (2022-07-01)

Expression of PD-1 mitigates phagocytic activities TAM in osteosarcoma
by: Chenhong Zheng, et al.
Published: (2024-01-01)

Increased expression of PD-L1 in endometrial cancer stem-like cells is regulated by hypoxia
by: Shasha Yin, et al.
Published: (2022-01-01)

PD-L1 regulation by SDH5 via β-catenin/ZEB1 signaling
by: Zhan Tuo, et al.
Published: (2019-12-01)

Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors
by: Kazuhiko Hashimoto, et al.
Published: (2023-04-01)

Hepatoid adenocarcinoma of the lung with PD-L1 expression and the response to anti-PD-1 therapy: a case report
by: Yan Li, et al.
Published: (2023-11-01)

PD-L1/PD-L2-expressing B-1 cells inhibit alloreactive T cells in mice.
by: Takayuki Hirose, et al.
Published: (2017-01-01)

PD-1 and PD-L1 expression in rare lung tumors
by: Marton Gyulai, et al.
Published: (2023-05-01)

The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells
by: Yu Wang, et al.
Published: (2020-07-01)

Correction: KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
by: Jinghan Li, et al.
Published: (2025-01-01)

A change of PD-1/PD-L1 expression on peripheral T cell subsets correlates with the different stages of Alzheimer's Disease
by: Ching-Tse Wu, et al.
Published: (2022-09-01)

Meta-analysis of the correlation between glioma prognosis and PD-1/PD-L1 expression
by: Chang-cheng Ren, et al.
Published: (2023-12-01)

L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression
by: Yuanyuan Zhang, et al.
Published: (2022-06-01)